Genetic diagnosis of familial hypercholesterolemia is associated with a premature and high coronary heart disease risk.

Patients with mutation+ FH have a more atherogenic lipid profile and a 3-fold higher risk of premature CHD, as well as earlier onset of CHD, than patients with mutation- FH.